KRO-49052

2-(1-Piperazinyl)pyridine; 1-(Pyridin-2-yl)piperazine; 1-(2-Pyridyl)Piperazine; 2-Piperazinopyridine; 2-pyridylpiperazine

34803-66-2
98% min.
scale-up (10-1,000 kg)
C9H13N3

KRO-37874

2-(6-chloropyridin-3-yl)acetonitrile; 2-Chloro-5-(cyanomethyl)pyridine,6-Chloro-3-pyridylacetonitrile; 2-(6-Chloro-3-pyridinyl)acetonitrile; 2-Chloro-5-(cyanomethyl)pyridine; 2-Chloropyridine-5-acetonitrile

39891-09-3
98% min.
scale-up (10-1,000 kg)
C7H5ClN2

KRO-16707

A-KetoglutaricAcidMonopotassiumSalt; A-KETOGLUTARIC ACID MONOPOTASSIUM; 2-Oxopentanedioic acid potassium salt; 2-OXOGLUTARIC ACID MONOPOTASSIUM SALT; 2-Ketoglutaric Acid Monopotassium; 2-KETOGLUTARIC ACID POTASSIUM SALT; Potasium hydrogen 2-ketoglutarate

997-43-3
98% min.
scale-up (10-1,000 kg)
C5H5KO5

KRO-14972

Fmoc-L-3-Chlorophenylalanine; fmoc-l-3-chlorophe; fmoc-l-3-chloro-phe-oh; fmoc-3-chloro-l-phenylalanine; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chlorophenyl)propanoic acid

198560-44-0
98% min.
scale-up (10-1,000 kg)
C24H20ClNO4

KRO-00642

UNII-045A6V3VFX; indium powder; Indium; EINECS 231-180-0; indio

7440-74-6
98% min.
scale-up (10-1,000 kg)
In

KRO-11611

5-((4-(6-chlorothieno[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile

866206-54-4
98% min.
scale-up (10-1,000 kg)
C19H17ClFN5S

KRO-10086

(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide; Met Kinase Inhibitor; (3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxoindoline-5-sulfonamide

658084-23-2
98% min.
scale-up (10-1,000 kg)
C28H30ClN5O4S

KRO-13780

XL 147,XL-147; XL147; PI3K inhibitor X

956958-53-5
98% min.
scale-up (10-1,000 kg)
C21H16N6O2S2

KRO-07817

Bosutinib(SKI 606); SKI-606; Bosutinib for research; BOSUTINIB; Bosutinib (SKI-606); Bosutinib

380843-75-4
98% min.
scale-up (10-1,000 kg)
C26H29Cl2N5O3

KRO-07548

Edurant; TMC-278; 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile; UNII-FI96A8X663; Rilpivirine; [3H]-Rilpivirine

500287-72-9
98% min.
scale-up (10-1,000 kg)
C22H18N6

KRO-07824

1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine,dihydrochloride; Vanoxerine hydrochloride; Vanoxerine dihydrochloride; I 893; 1-[2-[bis(4-fluorophenyl)methoxy]-ethyl]-4-[3-phenylpropyl]piperazine dihydrochloride

67469-78-7
98% min.
scale-up (10-1,000 kg)
C28H34Cl2F2N2O

KRO-14760

GDC-0941; 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine; GDC-0941 bismesylate; Pictilisib

957054-30-7
98% min.
scale-up (10-1,000 kg)
C23H27N7O3S2

KRO-05149

(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide; Dolutegravir; Tivicay

1051375-16-6
98% min.
scale-up (10-1,000 kg)
C20H19F2N3O5

KRO-11694

2-​Propen-​1-​one, 1-​[(3R)​-​3-​[4-​amino-​3-​(4-​phenoxyphenyl)​-​1H-​pyrazolo[3,​4-​d]​pyrimidin-​1-​yl]​-​1-​piperidinyl]​-

936563-96-1
98% min.
scale-up (10-1,000 kg)
C25H24N6O2

KRO-16526

Nintedanib; Nintedanib (BIBF 1120)

928326-83-4
98% min.
scale-up (10-1,000 kg)
C31H33N5O4

KRO-00382

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2''-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1''-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid; Azilsartan (medoxomil); Azilsartan Medoxomil; Azilsartan kamedoxomil; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate; TAK 491; Azilsartan; [14C]-Azilsartan medoxomil; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2''-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate; UNII-LL0G25K7I2; azilsartanum medoxomilum; Edarbi

863031-21-4
98% min.
scale-up (10-1,000 kg)
C30H24N4O8

KRO-36655

Benzaldehyde,2-bromo-5-chloro; 2-BroMo-5-chlorobenzaldehyde; 5-chloro-2-bromobenzaldehyde; IIISHLMCTDMUHH-UHFFFAOYSA

174265-12-4
98% min.
scale-up (10-1,000 kg)
C7H4BrClO

KRO-14017

N-(1,1,3-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[1,2,4]thiadiazin-7-yl)-methanesulfonamide; N-(1,1,3-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2,4]thiadiazin-7-yl)-methanesulfonamide

1000312-84-4
98% min.
scale-up (10-1,000 kg)
C8H9N3O5S2

KRO-46842

(1S,2S)-cyclohexane-1,2-diamine,(2S,3S)-2,3-dihydroxybutanedioic acid

67333-70-4
98% min.
scale-up (10-1,000 kg)
C10H20N2O6

KRO-46976

(1R,2R)-(-)-Cyclohexane-1,2-Diamine L-Tartrate Salt; (1R,2R)-(+)-1,2-Cyclohexanediamine L-Tartrate; (1R,2R)-(+)-1,2-Diaminocyclohexane L-tartrate; (1R,2R)-Cyclohexane-1,2-diamine (2R,3R)-2,3-dihydroxysuccinate; (1R)-trans-1,2-Diaminocyclohexane L-Tartrate

39961-95-0
98% min.
scale-up (10-1,000 kg)
C10H20N2O6